Cardiff Oncology
CRDF
CRDF
55 hedge funds and large institutions have $7.58M invested in Cardiff Oncology in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $8.81M → $7.58M (-$1.22M)
47% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 15
Holders
55
Holding in Top 10
–
Calls
$363K
Puts
$83K
Top Buyers
| 1 | +$312K | |
| 2 | +$27.8K | |
| 3 | +$24.4K | |
| 4 |
JP Morgan Chase
New York
|
+$24.4K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$21K |
Top Sellers
| 1 | -$375K | |
| 2 | -$219K | |
| 3 | -$183K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$127K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$80.8K |